Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica S Little

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Blood Advances|June 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapyJessica S Little, Angelica Medina Pena, E Bridget Kim, et al.
Transplantation and Cellular Therapy|March 11, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy RecipientsMuneerah M Aleissa, Jessica S Little, Sonya Davey, et al.
The Lancet. Rheumatology|January 31, 2025
Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort studyKathleen M M Vanni, Kaitlin R McCarter, Xiaosong Wang, et al.
Open Forum Infectious Diseases|January 12, 2024
Immune Control in Repeated <i>Babesia microti</i> Infection in a Patient With B-Cell DeficiencyJessica S Little, Miranda S Oakley, Anna R Thorner, et al.
Transplantation and Cellular Therapy|November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor AllograftJessica S Little, Rémy Duléry, Roman M Shapiro, et al.
Transplantation and Cellular Therapy|September 23, 2025
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell TransplantationJessica S Little, Kyle M Hebert, Donna S Neuberg, et al.
The Journal of Infectious Diseases|January 5, 2026
Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case SeriesYuya Ito, Tracey-Ann Hoeltermann, Seher Anjum, et al.
Transplantation and Cellular Therapy|May 8, 2022
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release SyndromeJessica S Little, Roman M Shapiro, Muneerah M Aleissa, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2025
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort StudyLoukas Kakoullis, Carolyn D Alonso, Rebecca Burns, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Blood Advances|June 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapyJessica S Little, Angelica Medina Pena, E Bridget Kim, et al.
Transplantation and Cellular Therapy|March 11, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy RecipientsMuneerah M Aleissa, Jessica S Little, Sonya Davey, et al.
The Lancet. Rheumatology|January 31, 2025
Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort studyKathleen M M Vanni, Kaitlin R McCarter, Xiaosong Wang, et al.
Open Forum Infectious Diseases|January 12, 2024
Immune Control in Repeated <i>Babesia microti</i> Infection in a Patient With B-Cell DeficiencyJessica S Little, Miranda S Oakley, Anna R Thorner, et al.
Transplantation and Cellular Therapy|November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor AllograftJessica S Little, Rémy Duléry, Roman M Shapiro, et al.
Transplantation and Cellular Therapy|September 23, 2025
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell TransplantationJessica S Little, Kyle M Hebert, Donna S Neuberg, et al.
The Journal of Infectious Diseases|January 5, 2026
Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case SeriesYuya Ito, Tracey-Ann Hoeltermann, Seher Anjum, et al.
Transplantation and Cellular Therapy|May 8, 2022
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release SyndromeJessica S Little, Roman M Shapiro, Muneerah M Aleissa, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2025
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort StudyLoukas Kakoullis, Carolyn D Alonso, Rebecca Burns, et al.
Pageof 4